%0 Journal Article %A Natasha M Simske %A Trenton Rivera %A Bryan O Ren %A Alex Benedick %A Megen Simpson %A Mark Kalina %A Sarah B Hendrickson %A Heather A Vallier %T Implementation of programming for survivors of violence-related trauma at a level 1 trauma center %D 2021 %R 10.1136/tsaco-2021-000739 %J Trauma Surgery & Acute Care Open %P e000739 %V 6 %N 1 %X Background Prior investigation of violence intervention programs has been limited. This study will describe resources offered by Victims of Crime Advocacy and Recovery Program (VOCARP), their utilization, and effect on recidivism.Methods VOCARP was established in 2017 at our center, and all patients who engaged with programming (n=1019) were prospectively recorded. Patients are offered services in the emergency department, on inpatient floors and at outpatient clinic visits. Two control groups (patients sustaining violent injuries without VOCARP use (n=212) and patients with non-violent trauma (n=201)) were similarly aggregated.Results During 22 months, 96% of patients accepted education materials, 31% received financial compensation, 27% requested referrals, and 22% had crisis interventions. All other resources were used by <20% of patients. Patients who used VOCARP resources were substantially different from those who declined services; they were less often male (56% vs. 71%), more often single (79% vs. 51%), had greater unemployment (63% vs. 51%) and were less frequently shot (gunshot wound: 26% vs. 37%), all p<0.05. Overall recidivism rate was 9.4%, with no difference between groups. Use of mental health services was linked to lower recidivism rates (4.4% vs. 11.7%, p=0.016). While sexual assault survivors who used VOCARP resources had lower associated recidivism (2.4% vs. 12%, p=0.14), this was not statistically significant.Discussion This represents the largest violence intervention cohort reported to date to our knowledge. Despite substantial engagement, efficacy in terms of lower recidivism appears limited to specific subgroups or resource utilization.Level of evidence Level II. Therapeutic.Data are available upon reasonable request. %U http://tsaco.smart01.highwire.org/content/tsaco/6/1/e000739.full.pdf